Xeris Pharmaceuticals | Rentekostnader



Interest Expense On Debt Endring Dato
Celltrion KRW 18.38B 907.05M 2024-09
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ecofibre AUD 761K 773K 2024-06
Eli Lilly USD 224.7M 78.4M 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Neuren Pharmaceuticals 0 0 2024-06
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Qiagen NV USD 11.14M 337K 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
Tilray USD 7.77M 2.08M 2024-11
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Xeris Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.